Aging · 2017 · 22 citations · 31 references
MedicineMolecular BiologyOncologyEpigeneticsMolecular OncologyTumor ProgressionCancer EpigeneticsEpigenetic Alterations In CancerEpigenetic Regulation In CancerGlioblastomaMicrorna BiologyMolecular Tumor ProfilingEpigenetic Gene SilencingEpigenetic SilencingGlioblastoma EpigeneticsLuciferase Reporter AssaysMalignant ProgressionMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In Cancer
, which ultimately prevented binding of PKM2 to β-catenin and reduced T-cell factor/lymphoid enhancer factor reporter gene transcriptional activity. MiR-338 also inhibited PKM2 expression, attenuated glioma growth and prolonged survival in an animal model. These results confirm that miR-338, a tumor suppressor, suppresses the PKM2/β-catenin axis and is downregulated in glioblastoma. This provides a theoretical basis for glioma-targeting therapy.
31
Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi
Scott M. Hammond, Sabrina Boettcher, Amy A. Caudy et al. · Science · 2001 · 1.5K citations
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Weiwei Yang, Yan Xia, Haitao Ji et al. · Nature · 2011 · 1K citations · Full text